Bortezomib Active Not Recruiting Phase 2 Trials for Stage IV Breast Cancer / Estrogen Receptor Positive / Stage IIIB Breast Cancer / Recurrent Breast Carcinoma / Stage IIIC Breast Cancer / Stage III Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01142401Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer